Management of disease-related malnutrition for patients being treated in hospital.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
20 11 2021
Historique:
received: 14 04 2021
revised: 16 06 2021
accepted: 21 06 2021
pubmed: 18 10 2021
medline: 11 1 2022
entrez: 17 10 2021
Statut: ppublish

Résumé

Disease-related malnutrition in adult patients who have been admitted to hospital is a syndrome associated with substantially increased morbidity, disability, short-term and long-term mortality, impaired recovery from illness, and cost of care. There is uncertainty regarding optimal diagnostic criteria, definitions for malnutrition, and how to identify patients who would benefit from nutritional intervention. Malnutrition has become the focus of research aimed at translating current knowledge of its pathophysiology into improved diagnosis and treatment. Researchers are particularly interested in developing nutritional interventions that reverse the negative effects of disease-related malnutrition in the hospital setting. High-quality randomised trials have provided evidence that nutritional therapy can reduce morbidity and other complications associated with malnutrition in some patients. Screening of patients for risk of malnutrition at hospital admission, followed by nutritional assessment and individualised nutritional interventions for malnourished patients, should become part of routine clinical care and multimodal treatment in hospitals worldwide.

Identifiants

pubmed: 34656286
pii: S0140-6736(21)01451-3
doi: 10.1016/S0140-6736(21)01451-3
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1927-1938

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests PS reports grants from the Swiss National Science Foundation (PP00P3_150531), the Research Committee of the Kantonsspital Aarau (1410.000.058 and 1410.000.044), Nestle Health Science, and Abbott Nutrition. ZS reports grants from Nestle Health Science, Abbott Nutrition, Fresenius Kabi, and B Braun.

Auteurs

Philipp Schuetz (P)

University Department of Medicine, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland. Electronic address: schuetzph@gmail.com.

David Seres (D)

Department of Medicine, and Institute of Human Nutrition, Columbia University Irving Medical Center, New York, NY, USA.

Dileep N Lobo (DN)

Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, UK; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, School of Life Sciences, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK.

Filomena Gomes (F)

Nutrition Science Program, New York Academy of Sciences, New York, NY, USA; NOVA Medical School, Universidade NOVA de Lisboa, Lisboa, Portugal.

Nina Kaegi-Braun (N)

Division of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Kantonsspital Aarau, Aarau, Switzerland.

Zeno Stanga (Z)

Division of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH